Neurochemical Research

, Volume 43, Issue 3, pp 566–580 | Cite as

Excessive Activation of NMDA Receptors Induced Neurodevelopmental Brain Damage and Cognitive Deficits in Rats Exposed to Intrauterine Hypoxia

  • Ting Li
  • Ziqiang Luo
  • Yang Liu
  • Mingjie Wang
  • Xiaohe Yu
  • Chuanding Cao
  • Zhengchang Liao
  • Ying Ding
  • Shaojie Yue
Original Paper

Abstract

Intrauterine hypoxia is one of the most common stressors in fetuses, which can lead to abnormal brain development and permanent neurological deficits in adulthood. Neurological disorder excitotoxicity induced by hypoxia or ischemia may involve N-methyl-d-aspartate receptors (NMDARs), which are known to participate in the maturation and plasticity of developmental neurons. Inhibition of NMDARs has been reported to improve neurological outcomes in traumatic brain injuries and Alzheimer’s disease. Here, we investigated if antenatal blockade of NMDARs induced by memantine could alleviate neurodevelopmental brain damage and long-term cognitive deficits in intrauterine hypoxia rats. Pregnant rats were assigned to four groups: air control, air + memantine, hypoxia, and hypoxia + memantine. The rats were exposed to hypoxic conditions (FiO2 = 0.095–0.115) for 8 h/day (hypoxia group) or given a daily memantine injection (5 mg/kg, i.p.) before hypoxia exposure from pregnant day 19 (G19) to G20 (hypoxia + memantine group).The influence of NMDARs antenatal blockade by memantine on intrauterine hypoxia-induced brain developmental damage and cognitive function was then studied. Intrauterine hypoxia resulted in decreased fetal body weight, brain weight, cognitive function, hippocampal neuron numbers, and Ki-67 proliferation index in the hippocampus. Memantine preventive treatment in pregnant rats before hypoxia exposure alleviated the aforementioned damage in vivo. Excessive activation of NMDARs contributes to fetal brain developmental damage and cognitive ability impairment induced by intrauterine hypoxia, which could be alleviated by antenatal memantine preventative treatment.

Keywords

NMDA receptors Glutamate antagonist Memantine Intrauterine hypoxia Neurodevelopment 

Notes

Acknowledgements

The authors acknowledge all colleagues of the Department of Physiology, Xiangya Medical College, Central South University for technical assistance.

Funding

Funding was provided by National Science Foundation of China (Grant No. 81270121).

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no competing interest.

References

  1. 1.
    Miller SL, Huppi PS, Mallard C (2015) The consequences of fetal growth restriction on brain structure and neurodevelopmental outcome. J Physiol 594(4):807CrossRefGoogle Scholar
  2. 2.
    Volpe JJ (2001) Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50(5):553–562CrossRefPubMedGoogle Scholar
  3. 3.
    Mach M, Dubovický M, Navarová J, Brucknerová I, Ujházy E (2009) Experimental modeling of hypoxia in pregnancy and early postnatal life. Interdiscip Toxicol 2(1):28CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Sombati S, Coulter DA, Delorenzo RJ (1991) Neurotoxic activation of glutamate receptors induces an extended neuronal depolarization in cultured hippocampal neurons. Brain Res 566(1–2):316CrossRefPubMedGoogle Scholar
  5. 5.
    Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330(9):613CrossRefPubMedGoogle Scholar
  6. 6.
    Yue S (1994) The excitatory neurotoxicity of glutamic and the central nervous system injury. Foreign Med Sci Sect Neurol Neurosurg 4:205–208Google Scholar
  7. 7.
    Waters KA, Machaalani R (2004) NMDA receptors in the developing brain and effects of noxious insults. Neuro-Signals 13(4):162–174.  https://doi.org/10.1159/000077523 CrossRefPubMedGoogle Scholar
  8. 8.
    Ritter LM, Unis AS, Meador-Woodruff JH (2001) Ontogeny of ionotropic glutamate receptor expression in human fetal brain. Dev Brain Res 127(2):123–133CrossRefGoogle Scholar
  9. 9.
    Elizabeth GPD, Cameron HA, Mcewen BS (1994) Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus. J Comp Neurol 340(4):551CrossRefGoogle Scholar
  10. 10.
    Gould E, Cameron HA (1997) Early NMDA receptor blockade impairs defensive behavior and increases cell proliferation in the dentate gyrus of developing rats. Behav Neurosci 111(1):49CrossRefPubMedGoogle Scholar
  11. 11.
    Komuro H, Rakic P (1993) Modulation of neuronal migration by NMDA receptors. Science 260(5104):95CrossRefPubMedGoogle Scholar
  12. 12.
    Rakic P (1998) Images in neuroscience. Brain development, VI: radial migration and cortical evolution. Am J Psychiatry 155(9):1150–1151CrossRefPubMedGoogle Scholar
  13. 13.
    Bear MF, Cooper LN, Ebner FF (1987) A physiological basis for a theory of synapse modification. Science 237(4810):42–48CrossRefPubMedGoogle Scholar
  14. 14.
    Brooks WJ, Petit TL, Leboutillier JC, Lo R (1991) Rapid alteration of synaptic number and postsynaptic thickening length by NMDA: an electron microscopic study in the occipital cortex of postnatal rats. Synapse 8(1):41CrossRefPubMedGoogle Scholar
  15. 15.
    Mcdonald JW, Silverstein FS, Johnston MV (1988) Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 459(1):200–203CrossRefPubMedGoogle Scholar
  16. 16.
    Balázs R, Hack N, Jørgensen OS (1990) Interactive effects involving different classes of excitatory amino acid receptors and the survival of cerebellar granule cells in culture. Int J Dev Neurosci 8(4):347CrossRefPubMedGoogle Scholar
  17. 17.
    Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA (1995) Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92(16):7162–7166CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Herlenius E, Lagercrantz H (2001) Neurotransmitters and neuromodulators during early human development. Early Hum Dev 65(1):21–37CrossRefPubMedGoogle Scholar
  19. 19.
    Myseros JS, Bullock R (1995) The rationale for glutamate antagonists in the treatment of traumatic brain injury. Ann N Y Acad Sci 765(1):262–271CrossRefPubMedGoogle Scholar
  20. 20.
    Chen H, Liu Z, Zhou Z, Jiang M, Qian L, Wu S (2003) The regulatory effect of memantine on expression and synthesis of heat shock protein 70 gene in neonatal rat models with cerebral hypoxic ischemia. Chin Med J 116(4):558–564PubMedGoogle Scholar
  21. 21.
    Rao VL, Dogan A, Todd KG, Bowen KK, Dempsey RJ (2001) Neuroprotection by memantine, a non-competitive NMDA receptor antagonist after traumatic brain injury in rats. Brain Res 911(1):96CrossRefPubMedGoogle Scholar
  22. 22.
    Gao Y, Chen HJ, Qian LH, Chen GY (2006) Long-term effects of memantine therapy on neonatal rats with hypoxic-ischemic brain damage. Chin J Contemp Pediatr 8(1):38Google Scholar
  23. 23.
    Heidrich A, Rösler M, Riederer P (1997) Pharmacotherapy of Alzheimer dementia: therapy of cognitive symptoms-new results of clinical studies. Fortschr Neurol Psychiatr 65(3):108CrossRefPubMedGoogle Scholar
  24. 24.
    Parsons CG, Danysz W, Quack G (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist—a review of preclinical data. Neuropharmacology 38(6):735CrossRefPubMedGoogle Scholar
  25. 25.
    Liao Z, Zhou X, Luo Z, Huo H, Wang M, Yu X, Cao C, Ding Y, Xiong Z, Yue S (2016) N-methyl-D-aspartate receptor excessive activation inhibited fetal rat lung development in vivo and in vitro. Biomed Res Int 2016(5):5843981PubMedPubMedCentralGoogle Scholar
  26. 26.
    Kalynchuk LE, Pinel JP, Treit D, Barnes SJ, Mceachern JC, Kippin TE (1998) Persistence of the interictal emotionality produced by long-term amygdala kindling in rats. Neuroscience 85(4):1311–1319CrossRefPubMedGoogle Scholar
  27. 27.
    Albert DJ, Richmond SE (1975) Septal hyperreactivity: a comparison of lesions within and adjacent to the septum. Physiol Behav 15(3):339–347CrossRefPubMedGoogle Scholar
  28. 28.
    Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11(1):47–60CrossRefPubMedGoogle Scholar
  29. 29.
    Lubics A, Reglodi DA, Kiss P, Szalai M, Szalontay L, Lengvari I (2005) Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic-ischemic injury. Behav Brain Res 157(1):157–165CrossRefPubMedGoogle Scholar
  30. 30.
    Aboutaleb N, Kalalianmoghaddam H, Eftekhari S, Shahbazi A, Abbaspour H, Khaksari M (2014) Apelin-13 inhibits apoptosis of cortical neurons following brain ischemic reperfusion injury in a transient model of focal cerebral ischemia. Int J Pept Res Ther 20(2):127–132CrossRefGoogle Scholar
  31. 31.
    Gheibi S, Aboutaleb N, Khaksari M, Kalalian-Moghaddam H, Vakili A, Asadi Y, Mehrjerdi FZ, Gheibi A (2014) Hydrogen sulfide protects the brain against ischemic reperfusion injury in a transient model of focal cerebral ischemia. J Mol Neurosci 54(2):264–270CrossRefPubMedGoogle Scholar
  32. 32.
    Kee N, Sivalingam S, Boonstra R, Wojtowicz JM (2002) The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods 115(1):97–105CrossRefPubMedGoogle Scholar
  33. 33.
    Jang EA, Longo LD, Goyal R (2015) Antenatal maternal hypoxia: criterion for fetal growth restriction in rodents. Front Physiol 6:176CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Golan H, Kashtuzki I, Hallak M, Sorokin Y, Huleihel M (2004) Maternal hypoxia during pregnancy induces fetal neurodevelopmental brain damage: partial protection by magnesium sulfate. J Neurosci Res 78(3):430–441CrossRefPubMedGoogle Scholar
  35. 35.
    Golan H, Kashtutsky I, Hallak M, Sorokin Y, Huleihel M (2004) Maternal hypoxia during pregnancy delays the development of motor reflexes in newborn mice. Dev Neurosci 26(1):24CrossRefPubMedGoogle Scholar
  36. 36.
    Stocker CJ, Arch JRS, Cawthorne MA (2005) Fetal origins of insulin resistance and obesity. Proc Nutr Soc 64(2):143–151CrossRefPubMedGoogle Scholar
  37. 37.
    Ojeda NB, Grigore D, Alexander BT (2008) Intrauterine growth restriction: fetal programming of hypertension and kidney disease. Adv Chronic Kidney Dis 15(2):101–106CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Murray E, Fernandes M, Fazel M, Kennedy SH, Villar J, Stein A (2015) Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review. BJOG Int J Obstet Gynaecol 122(8):1062CrossRefGoogle Scholar
  39. 39.
    Forsén T, Eriksson J, Tuomilehto J, Reunanen A, Osmond C, Barker D (2000) The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 133(3):176CrossRefPubMedGoogle Scholar
  40. 40.
    Barker DJ, Osmond C, Forsén TJ, Kajantie E, Eriksson JG (2005) Trajectories of growth among children who have coronary events as adults. N Engl J Med 353(17):1802–1809CrossRefPubMedGoogle Scholar
  41. 41.
    Dulloo AG (2008) Thrifty energy metabolism in catch-up growth trajectories to insulin and leptin resistance. Best Pract Res Clin Endocrinol Metab 22(1):155–171CrossRefPubMedGoogle Scholar
  42. 42.
    Bromleybrits K, Deng Y, Song W (2011) Morris water maze test for learning and memory deficits in Alzheimer’s disease model mice. J Vis Exp JoVE 53:e2920–e2920Google Scholar
  43. 43.
    Mcnamara RK, Skelton RW (1993) The neuropharmacological and neurochemical basis of place learning in the Morris water maze. Brain Res Rev 18(1):33–49CrossRefPubMedGoogle Scholar
  44. 44.
    Jeffery KJ, Morris RG (1993) Cumulative long-term potentiation in the rat dentate gyrus correlates with, but does not modify, performance in the water maze. Hippocampus 3(2):133CrossRefPubMedGoogle Scholar
  45. 45.
    Morris RGM, Anderson E, Lynch GS, Baudry M (1986) Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319(6056):774–776CrossRefPubMedGoogle Scholar
  46. 46.
    Khalaf-Nazzal R, Francis F (2013) Hippocampal development—old and new findings. Neuroscience 248C(38):225CrossRefGoogle Scholar
  47. 47.
    Lüscher C, Malenka RC (2012) NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol 4(6):997–1001CrossRefGoogle Scholar
  48. 48.
    Burd I, Welling J, Kannan G, Johnston MV (2016) Chapter five—excitotoxicity as a common mechanism for fetal neuronal injury with hypoxia and intrauterine inflammation. Adv Pharmacol 76:85–101CrossRefPubMedGoogle Scholar
  49. 49.
    Chen HS, Wang YF, Rayudu PV, Edgecomb P, Neill JC, Segal MM, Lipton SA, Jensen FE (1998) Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 86(4):1121–1132CrossRefPubMedGoogle Scholar
  50. 50.
    Portera-Cailliau C, Price DL, Martin LJ (2015) Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J Comp Neurol 378(1):10–87CrossRefGoogle Scholar
  51. 51.
    Lipton SA, Nakanishi N (1999) Shakespeare in love-with NMDA receptors? Nat Med 5(3):270–271CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2017

Authors and Affiliations

  • Ting Li
    • 1
  • Ziqiang Luo
    • 2
  • Yang Liu
    • 1
  • Mingjie Wang
    • 1
  • Xiaohe Yu
    • 1
  • Chuanding Cao
    • 1
  • Zhengchang Liao
    • 1
  • Ying Ding
    • 1
  • Shaojie Yue
    • 1
  1. 1.Department of Pediatrics, Xiangya HospitalCentral South UniversityChangshaChina
  2. 2.Department of Physiology, Xiangya Medical SchoolCentral South UniversityChangshaChina

Personalised recommendations